United States · FDA National Drug Code directory

EPTIFIBATIDE

Source ingredient · 21 source records

Names are grouped within this source and country. A shared ingredient does not establish interchangeable medicines.

United States · Source reference 0338-9558_a90f397a-95b8-421c-9e34-b327671f97a3

Eptifibatide

INJECTION / Baxter Healthcare Company

United States · Source reference 52958-040_6f3dec26-ea9b-4e6e-8e5b-0fa6fb430598

Eptifibatide

INJECTION, SOLUTION / Hainan Shuangcheng Pharmaceuticals Co., Ltd.

United States · Source reference 52958-402_6f3dec26-ea9b-4e6e-8e5b-0fa6fb430598

Eptifibatide

INJECTION, SOLUTION / Hainan Shuangcheng Pharmaceuticals Co., Ltd.

United States · Source reference 55150-218_944b269c-d810-411d-9ed4-8edd9d0ac1b7

Eptifibatide

INJECTION / Eugia US LLC

United States · Source reference 55150-219_944b269c-d810-411d-9ed4-8edd9d0ac1b7

Eptifibatide

INJECTION / Eugia US LLC

United States · Source reference 55150-220_944b269c-d810-411d-9ed4-8edd9d0ac1b7

Eptifibatide

INJECTION / Eugia US LLC

United States · Source reference 67457-629_e966c894-560e-4805-bdd5-16e153bb4687

Eptifibatide

INJECTION, SOLUTION / Mylan Institutional LLC

United States · Source reference 67457-630_e966c894-560e-4805-bdd5-16e153bb4687

Eptifibatide

INJECTION, SOLUTION / Mylan Institutional LLC

United States · Source reference 67457-631_e966c894-560e-4805-bdd5-16e153bb4687

Eptifibatide

INJECTION, SOLUTION / Mylan Institutional LLC

United States · Source reference 70436-026_4a613f2d-85b3-d45c-e063-6294a90adb93

Eptifibatide

INJECTION / Slate Run Pharmaceuticals, LLC

United States · Source reference 70436-027_4a613f2d-85b3-d45c-e063-6294a90adb93

Eptifibatide

INJECTION / Slate Run Pharmaceuticals, LLC

United States · Source reference 70436-162_4a614df8-4e1d-d610-e063-6294a90a7d7c

Eptifibatide

INJECTION / Slate Run Pharmaceuticals, LLC

United States · Source reference 70436-163_4a614df8-4e1d-d610-e063-6294a90a7d7c

Eptifibatide

INJECTION / Slate Run Pharmaceuticals, LLC

United States · Source reference 71288-412_a15dafa6-7923-4999-8938-28e580304e57

Eptifibatide

INJECTION, SOLUTION / Meitheal Pharmaceuticals Inc.

United States · Source reference 71288-413_a15dafa6-7923-4999-8938-28e580304e57

Eptifibatide

INJECTION, SOLUTION / Meitheal Pharmaceuticals Inc.

United States · Source reference 72078-025_7af20acf-ba9f-4387-9729-85d3c137f41e

Eptifibatide

INJECTION, SOLUTION / Mylan Institutional LLC

United States · Source reference 72078-026_7af20acf-ba9f-4387-9729-85d3c137f41e

Eptifibatide

INJECTION, SOLUTION / Mylan Institutional LLC

United States · Source reference 72078-027_7af20acf-ba9f-4387-9729-85d3c137f41e

Eptifibatide

INJECTION, SOLUTION / Mylan Institutional LLC

United States · Source reference 83634-300_2be68459-cc94-4be1-850d-630afc162032

Eptifibatide

INJECTION, SOLUTION / Avenacy, LLC

United States · Source reference 83634-301_2be68459-cc94-4be1-850d-630afc162032

Eptifibatide

INJECTION, SOLUTION / Avenacy, LLC

United States · Source reference 25021-408_7e4a3720-9c2e-4fb7-b703-f896f7fd0686

eptifibatide

INJECTION, SOLUTION / Sagent Pharmaceuticals

Browse ingredients in United States →